On ECHEMI
Home > Drugs > Xinrong Granules

Xinrong Granules

Function and Efficacy

1. Xinrong significantly improves the ischemic and hypoxic state of rat myocardial ischemic and hypoxic necrosis caused by isoproterenol, reduces myocardial oxygen consumption, and significantly alleviates myocardial necrosis. 2. Xinrong has a significant protective effect on the damage caused by isoproterenol to rat and neonatal myocardial cells cultured in vitro. 3. Xinrong has a certain improvement on the electrocardiogram of myocardial obstructive ischemic injury caused by coronary artery ligation in rats, and has a significant effect on reducing the increased activity of plasma lactate dehydrogenase (LDH) and creatine phosphokinase (CPK) in rats and the increased content of plasma free fatty acids (FFA). 4. Xinrong can significantly reduce the TBA value in plasma of rat J myocardial necrosis caused by isoproterenol, play an anti-lipid peroxidation role, and significantly reduce the activity of enzymes such as EBDH and CPK in plasma. 5 The SWANGANZ floating catheter experiment was used to observe the acute hemodynamic effects of Xinrong on patients with congestive heart failure. The results showed that this product can reduce pulmonary artery pressure (MPAP), pulmonary wedge pressure (PCWP), and increase cardiac index (C1). 6 It can increase the activity of superoxide dismutase (SOD) in red blood cells of patients with myocardial injury and reduce the content of lipid peroxide (LPO) in plasma.

Ingredients

Astragalus, Rehmannia root, Ophiopogon japonicus, Schisandra chinensis, Red Peony Root, Cinnamon Twig

Name Description Content CAS NO. Manufacturer
Anise oilIngredients

Improve myocardial ischemia and hypoxia, reduce myocardial oxygen consumption, and alleviate myocardial necrosis; have a protective effect on myocardial cell damage; resist lipid peroxidation, reduce the activity of hydroxybutyrate dehydrogenase and creatine phosphokinase in plasma; reduce pulmonary artery pressure and pulmonary wedge pressure, and improve cardiac index; increase erythrocyte superoxide dismutase activity and reduce lipid peroxide content.

More
8007-70-3 10

Appearance

This product is in the form of granules.

Usage and Dosage

Oral administration. 5 capsules at a time (or one bag at a time, or 2 sticks at a time), 3 times a day, for 6 weeks or as directed by your doctor.

Adverse Reactions

. Dry mouth, nausea, and bowel movements may occasionally occur, but generally do not affect treatment.

Precautions

Use with caution in pregnant women.

Special Population Medication

Precautions during pregnancy and lactation: Use with caution in pregnant women.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

Sealed in a cool, dry place.

Packaging Specification

5g per bag (no sucrose)

Validity Period

18 months

Manufacturer

Anhui Joyfar Pharmaceutical Co., Ltd.

  • Founded in:

    1997-12-08
  • Address:

    Anhui Bozhou Economic Development Zone
  • Tax NO.:

    91341600151945984H
  • Registered Funds:

    45 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.